[Clinical experiences with synthetic ACTH (Synacthen)].
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000138:chemical synthesis / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003873:Dermatitis, Exfoliative / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000139:chemically induced; D010392:Pemphigus / Q000188:drug therapy; D010859:Pigmentation Disorders / Q000139:chemically induced; D011565:Psoriasis / Q000139:chemically induced
D000324:Adrenocorticotropic Hormone
Klinische Erfahrungen mit synthetischem ACTH (Synacthen)